ANTAGONIS BIOTHERAPEUTICS GMBH

Follow

Organization

Graz, AT

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Glycosaminoglycan-antagonising fusion proteins
- Patent number 10,703,790
- Issue date Jul 7, 2020
- Antagonis Biotherapeutics GmbH
- Andreas Kungl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycosaminoglycan-antagonising fusion proteins and methods of using...
- Patent number 10,047,133
- Issue date Aug 14, 2018
- Antagonis Biotherapeutics GmbH
- Andreas Kungl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
T-CELL MOBILIZING CXCL10 MUTANT WITH INCREASED GLYCOSAMINOGLYCAN BI...
- Publication number 20220281934
- Publication date Sep 8, 2022
- ANTAGONIS BIOTHERAPEUTICS GMBH
- Andreas Kungl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL GLYCOSAMINOGLYCAN-ANTAGONISING FUSION PROTEINS AND METHODS OF...
- Publication number 20180371043
- Publication date Dec 27, 2018
- ANTAGONIS BIOTHERAPEUTICS GMBH
- Andreas Kungl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL GLYCOSAMINOGLYCAN-ANTAGONISING FUSION PROTEINS AND METHODS OF...
- Publication number 20170058012
- Publication date Mar 2, 2017
- ANTAGONIS BIOTHERAPEUTICS GMBH
- Andreas Kungl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks